In Depth 2 Apr 2025
Beyond amyloid: The search for the next big thing in Alzheimer’s treatment
Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments.
- Latest Posts
In Depth 1 Apr 2025
The biggest biotech funding rounds in March 2025
The companies Isomorphic Labs, DBV Technologies, and Genfit bagged the biggest biotech funding rounds overall in March 2025.
News and Trends 31 Mar 2025
AstraZeneca bets on Asia: a surge of deals in March amid fraud probe
AstraZeneca has vowed to spend over $10 billion in Asia, particularly in China, to build Beijing into an R&D hub amid probe into fraud scandals.
Podcast 28 Mar 2025
Treating spinal cord injuries with stem cells
Listen to our talk with Brian Culley, CEO of Lineage Cell Therapeutics, about the potential of stem cells in spinal cord injuries
Best in Biotech 27 Mar 2025
12 AI drug discovery companies you should know about
Take a look at 12 of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process.
In Depth 26 Mar 2025
A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations
Delve into the kinase inhibitors’ diverse landscape, from cancer breakthroughs to autoimmune disease innovations.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 25 Mar 2025
These 7 biotechs are shaping the next generation of endometriosis care
As we observe Endometriosis Awareness Month in March, let us take a look at seven biotechs advancing promising candidates in the clinic.
News and Trends 25 Mar 2025
AbbVie and Genmab: Can a legal battle break a billion-dollar bond?
As AbbVie accuses Genmab of unlawfully using proprietary ADC technology, find out about their collaboration and the dispute opposing them.
News and Trends 24 Mar 2025
First-ever RIPTAC enters clinic: all you need to know about this new cancer approach
The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.
News and Trends 21 Mar 2025
Depression drug trials are failing—and placebos are to blame
In this article, we examine recent clinical trial failures and discuss potential pathways forward for antidepressant drug research.
Podcast 21 Mar 2025
Are mitochondrial therapeutics about to go mainstream?
Listen to our talk with Klaus Dugi, CEO of Vandria, about mitochondrial therapeutics and longevity
Interview 20 Mar 2025
AI meets biotech: Bullfrog AI’s CEO on the TechBio boom
Find out about how TechBios are changing the industry by leveraging AI and partnering with biotech in our interview with Bullfrog AI’s CEO.
ADVERTISEMENT
